^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    ctDNAaccuPanel™ Lung

    Company:
    NGeneBio
    Type:
    Laboratory Developed Test
    Related tests:
    Details
    Evidence

    News

    over1year
    EnGenBio participates in the World Lung Cancer Society… Introducing a product that can predict lung cancer recurrence and prognosis using blood (NGeneBio Press Release)
    "NGenBio has developed 'ctDNAaccuPanel™ Lung', a lung cancer precision diagnosis technology that analyzes with high precision information on circulating tumor DNA (ctDNA) present in trace amounts in the blood using 'Liquid Biopsy' technology from the World Lung Cancer Association.' is scheduled to be presented."
    Clinical
    |
    ctDNAaccuPanel™ Lung